Related Experiment Video
Updated: Jun 28, 2026
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Drug resistance and DNA repair in leukaemia
Abstract:
Most cytotoxic agents exert their action via damage of DNA. Therefore, the repair of such lesions is of major importance for the sensitivity of malignant cells to chemotherapeutic agents. The underlying mechanisms of various DNA repair pathways have extensively been studied in yeast, bacteria and mammalian cells. Sensitive and drug resistant cancer cell lines have provided models for analysis of the contribution of DNA repair to chemosensitivity. However, the validity of results obtained by laboratory experiments with regard to the clinical situation is limited. In both acute and chronic leukaemias, the emergence of drug resistant cells is a major cause for treatment failure. Recently, assays have become available to measure cellular DNA repair capacity in clinical specimens at the single-cell level. Application of these assays to isolated lymphocytes from patients with chronic lymphatic leukaemia (CLL) revealed large interindividual differences in DNA repair rates. Accelerated O(6)-ethylguanine elimination from DNA and faster processing of repair-induced single-strand breaks were found in CLL lymphocytes from patients nonresponsive to chemotherapy with alkylating agents compared to untreated or treated sensitive patients. Moreover, modulators of DNA repair with different target mechanisms were identified which also influence the sensitivity of cancer cells to alkylating agents. In this article, we review the current knowledge about the contribution of DNA repair to drug resistance in human leukaemia.
Insights
DNA repair capacity significantly impacts chemotherapy effectiveness in leukemia. Patients with nonresponsive chronic lymphatic leukemia showed faster DNA repair, indicating a link between DNA repair rates and drug resistance.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Cytotoxic chemotherapy agents primarily damage DNA, making DNA repair mechanisms crucial for cancer cell sensitivity.
- Drug resistance in leukemia, particularly acute and chronic forms, is a significant barrier to successful treatment.
- Understanding DNA repair's role in chemosensitivity is vital for improving leukemia therapies.
Purpose of the Study:
- To review the current understanding of DNA repair's contribution to drug resistance in human leukemia.
- To explore the clinical relevance of DNA repair capacity measurements in leukemia patients.
- To identify potential modulators of DNA repair that influence cancer cell sensitivity to alkylating agents.
Main Methods:
- Analysis of DNA repair pathways in various model organisms and cell lines.
- Utilizing sensitive and drug-resistant cancer cell lines to study DNA repair's impact on chemosensitivity.
- Employing novel single-cell level assays to measure DNA repair capacity in clinical leukemia specimens, specifically lymphocytes.
Main Results:
- Significant interindividual variations in DNA repair rates were observed in chronic lymphatic leukemia (CLL) patients.
- CLL lymphocytes from chemotherapy-nonresponsive patients exhibited accelerated O(6)-ethylguanine elimination and faster repair of single-strand breaks.
- Modulators influencing DNA repair mechanisms were identified, affecting cancer cell sensitivity to alkylating agents.
Conclusions:
- DNA repair capacity is a critical factor determining drug resistance in human leukemia.
- Single-cell DNA repair assays in clinical specimens offer valuable insights into patient response to chemotherapy.
- Targeting DNA repair pathways presents a promising strategy for overcoming drug resistance in leukemia treatment.
Related Concept Videos
02:56Treatment Resistant Cancers
02:25Overview of DNA Repair
Chemically...
02:25Overview of DNA Repair
Chemically...
01:38Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
01:08Nucleotide Excision Repair
01:08Nucleotide Excision Repair